Am J Transplant, Volume 20, Suppl 3 Archives - Page 136 of 223 - ATC Abstracts

2020 American Transplant Congress
Clinical Outcomes from a Mobile Health, Pharmacist-Led Intervention: 12-Month Results of the Transafe Rx Randomized Controlled Trial
D. Taber, J. Hirsch, Z. Su, J. McGillicuddy, A. Posadas, J. Fleming
Med Univ of South Carolina, Charleston, SC
*Purpose: Medication errors and non-adherence are predominant causes of poor graft outcomes in kidney transplant (KTX) recipients. The primary aim of the TRANSAFE Rx RCT…
2020 American Transplant Congress
Temporal Trends in Utilization and Outcomes of Sclerotic Donor Kidneys in the United States
J. D. Motter, K. R. Jackson, J. J. Long, A. B. Massie, N. M. Desai, D. L. Segev, J. M. Garonzik-Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Sclerotic donor kidneys (SDK, glomerulosclerosis ≥20% on biopsy) represent a possible expansion to the donor pool but are often discarded due to historical association…
2020 American Transplant Congress
Effect of Maintaining Immunosuppression after Kidney Graft Failure on Mortality and Re-Transplantation
C. Schinstock, S. Balakrishnan, A. Bentall, M. Merzkani, M. Stegall
Mayo Clinic, Rochester, MN
*Purpose: Patients with a failed renal allograft are at high risk for mortality. The potential benefit of maintaining immunosuppression with the intent to minimize sensitization…
2020 American Transplant Congress
Early Outcomes with the Liver-Kidney Safety Net
R. M. Cannon¹, D. S. Goldberg², D. E. Eckhoff¹, D. J. Anderson¹, B. J. Orandi¹, J. E. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Miami, Miami, FL
*Purpose: A safety net policy was implemented in August 2017 giving liver alone recipients with significant renal dysfunction post-transplant priority for subsequent renal transplantation. This…
2020 American Transplant Congress
Impact of Nursing Education on Organ Donation
J. Yeh¹, M. Corcoran², M. Jarrett², V. Nair¹, L. Teperman¹
¹Northwell Health, Manhasset, NY, ²Northwell Health, New Hyde Park, NY
*Purpose: Organ transplantation is the gold-standard for patients with end-stage organ disease. For organ donation to occur, potential donors need to be identified and referred…
2020 American Transplant Congress
Outcome of and Risk Factor for Pancreas Transplants with Marginal Donors
A. Gruessner, S. Saggi, J. Renz, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Over the years, the selection criteria for a pancreas donor changed with the decline in numbers of transplants. More and more younger donors with…
2020 American Transplant Congress
Assessing Immunosuppression with Immunological Testing and Surveillance Biopsies Late after Liver and Intestine Transplantation (LT, IT)
L. Remaley, R. Falik, K. Soltys, G. Bond, J. Winnier, P. Kachmar, C. Ashokkumar, A. Ganoza, A. Kepler, A. Khanna, J. Squires, P. McKiernan, J. Rudolph, F. Alissa, G. Mazariegos, R. Sindhi
Pediatric Transplant, Pittsburgh, PA
*Purpose: Assessing adequacy of immunosuppression is essential during late allograft surveillance after LT or IT.*Methods: To explain why allograft function tests can be normal despite…
2020 American Transplant Congress
Liver Transplant Outcomes Across the Age Distribution and Interactions with County Health
S. K. Niazi¹, E. Vargas², A. Spaulding³, J. Crook², T. Schneekloth⁴, A. Keaveny⁵, A. Vasquez⁶, M. Gentry⁴, T. Rummans⁶, C. Taner⁵
¹Psychiatry & Psychology; Transplantation, Mayo Clinic, Jacksonville, FL, ²Health Sciences Research, Mayo Clinic, Jacksonville, FL, ³Heath Sciences Research, Mayo Clinic, Jacksonville, FL, ⁴Psychiatry & Psychology, Mayo Clinic, Rochester, MN, ⁵Transplantation, Mayo Clinic, Jacksonville, FL, ⁶Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL
*Purpose: We examined risk of graft failure and patient mortality after liver transplant (LT) across the age continuum and county Health Outcomes & Health Factors…
2020 American Transplant Congress
Analyzing Causes for Death-Censored Graft Failure
M. Mayrdorfer, L. Liefeldt, N. Lachmann, W. Düttmann-Rehnolt, F. Halleck, M. G. Naik, P. Glander, K. Budde
Charité Universitätsmedizin Berlin, Berlin, Germany
*Purpose: Since it has been proposed that several causes could contribute to graft loss (GL), we analyzed graft failure in our center and attributed a…
2020 American Transplant Congress
Preclinical Study for Liver Allograft Tolerance after Rapid Immunosuppression Withdrawal Using Cynomolgus Monkeys
H. Sakai¹, E. Berglund¹, S. Chaudhry¹, Y. Kato¹, J. Weiner¹, P. Alonso-Guallart¹, N. Llore¹, K. Bruestle¹, F. Fredriksson¹, J. Stern¹, D. Ekanayake-Alper¹, M. Martinez², G. Pierre¹, M. Danton¹, S. Kofman¹, D. Ordanes¹, J. Lefkowitch³, A. Iuga¹, T. Kato⁴, M. Sykes¹, A. Griesemer¹
¹Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, ²Department of Pediatrics, Columbia University, New York, NY, ³Departments of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY
*Purpose: Operational tolerance of liver allografts occurs in highly selected patients but cannot be reliably induced. Herein, we investigated if tolerance to liver can be…